MeSH D005921 - glomerulonephritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009393:Nephritis
0 Companies
0 Drugs
Success rate
D005921:
Glomerulonephritis
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
33%1/3
Phase 2
43%9/21
Phase 3
31%5/16
Approved: 5Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use